Mohammed Milhem
Clinical trials sponsored by Mohammed Milhem, explained in plain language.
-
New combo shows promise in advanced kidney cancer trial
Disease control CompletedThis study tested a combination of two drugs—axitinib and seleniomethionine—in 45 adults with advanced kidney cancer that had spread. The goal was to find the safest dose and see if the combo could shrink tumors. While not a cure, the approach aims to better control the disease i…
Phase: PHASE1, PHASE2 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated May 26, 2026 10:12 UTC
-
Could a 70-year-old antipsychotic drug help fight deadly brain cancer?
Disease control CompletedThis early-phase study tested whether adding chlorpromazine, a medication used for mental health conditions, to standard chemotherapy and radiation is safe for people with newly diagnosed glioblastoma, an aggressive brain cancer. Ten adult patients participated to find the best d…
Phase: PHASE1 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated May 19, 2026 12:00 UTC